Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antisense oligodeoxynucleotides

C A Stein1, R Narayanan

  • 1Department of Medicine, Columbia University, New York, NY 10032.

Current Opinion in Oncology
|November 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and Validation of Obesity Interpreter: A Mobile Application-Based Tool for Children and Adolescents.

Indian pediatrics·2026
Same author

Distinguishing Between SIAD and Cerebral Salt Wasting: Is Dynamic Copeptin Response the Answer?

Indian journal of pediatrics·2026
Same author

Clinical Course and Predictors of Metabolic Dysfunction Associated Steatotic Liver Disease in Obese Children and Adolescents.

Indian pediatrics·2026
Same author

Answer to the letter to the editor of T. Tanaka, et al. concerning "patients on antidepressants are more likely to be discharged to inpatient rehabilitation after lumbar fusion" by J. Dalton, et al. (Eur spine J 2025: doi: 10.1007/s00586-025-08815-y).

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·2025
Same author

Muscadine Grape Skin Extract in Biochemically Recurrent Prostate Cancer: A Randomized, Placebo-Controlled, Biomarker-Enriched Trial in Patients With the SOD2 Ala/Ala Variant.

The Prostate·2025
Same author

Hyperglycemic Hyperosmolar State as a First Presentation of Type 1 Diabetes Mellitus.

Indian journal of pediatrics·2025
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Phosphorothioate oligodeoxynucleotides show promise as gene expression inhibitors due to nuclease resistance and entry into clinical trials. Further research is needed to address issues like cellular uptake and specificity for therapeutic applications.

Area of Science:

  • Molecular Biology
  • Oligonucleotide Therapeutics
  • Gene Expression Regulation

Background:

  • Oligodeoxynucleotides offer specific gene expression inhibition via Watson-Crick hybridization.
  • Standard phosphodiester oligodeoxynucleotides are unsuitable as drugs due to nuclease sensitivity.

Purpose of the Study:

  • To review the progress and challenges of phosphorothioate oligodeoxynucleotides as therapeutic agents.
  • To highlight the need for improved understanding of cellular mechanisms for effective clinical translation.

Main Methods:

  • Investigation of phosphorothioate oligodeoxynucleotides as nuclease-resistant DNA analogs.
  • In vitro studies targeting specific messenger RNAs (e.g., bcr-abl, bcl2).
  • Development of strategies to enhance intracellular oligodeoxynucleotide concentrations.

Related Experiment Videos

Main Results:

  • Phosphorothioate oligodeoxynucleotides demonstrate nuclease resistance and have advanced to clinical trials.
  • Targeting of specific disease-related messenger RNAs has been demonstrated.
  • Methods for increasing intracellular concentrations have been explored.

Conclusions:

  • Phosphorothioate oligodeoxynucleotides represent a promising therapeutic strategy for gene expression inhibition.
  • Challenges including nonsequence specificity, cellular uptake, and compartmentalization require further investigation.
  • Enhanced understanding of these factors is crucial for developing oligodeoxynucleotide-based therapies.